At the beginning of the year, ChinaPeptides was committed to accelerating the empowerment of scientific research in the field of biomedicine. ChinaPeptides has always insisted on providing high-quality products and services for scientific researchers, successfully helping many scientific research institutions to complete major national scientific research projects, and helping to publish SCI literature.

In 2022 alone, ChinaPeptides helped to publish 455 SCI documents, with 95 highly rated documents with an impact factor of more than 10. It was highly praised by customers for its high-quality product quality. Today, we have sorted out several excellent documents as the first issue of selected papers, and will launch a series of articles from time to time for your reference.

With ingenious research and development and strict adherence to quality, people of ChinaPeptides have never relaxed their pursuit of professionalism. At present, in addition to conventional polypeptide synthesis, protein expression, antibody preparation and related testing services, ChinaPeptides mainly focuses on RGD-like cyclopeptides, disulfide linked cyclopeptides, C-terminal labeling technology, N-terminal labeling technology, multiple fluorescent labeling technology, phosphorylation labeling technology, glycopeptide synthesis We hope to help more researchers accelerate the experimental progress and complete more important scientific research projects in the future.